Author(s): B. V. Naresh


DOI: 10.5958/2231-5691.2020.00040.4   

Address: B. V. Naresh*
Doctor of Pharmacy, University College of Pharmaceutical Sciences, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India.
*Corresponding Author

Published In:   Volume - 10,      Issue - 3,     Year - 2020

Corona viruses are a large family of viruses which may cause illness in animals or humans. In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle east respiratory syndrome (MERS) and Severe acute respiratory syndrome (SARS). The most recently discovered was coronavirus disease COVID-19 also known as Severe acute respiratory syndrome-2(SARS COV-2). In a short span, it has captured global consciousness by significantly affecting the day-to-day life of human beings. Currently, as a global pandemic, COVID-19 poses major challenges. It is a respiratory illness that can spread from person to person that was first identified in Wuhan, China. The World Health Organization has declared this as a Public health emergency of International Concern. Based on the current published evidence, this article summarizes the epidemiology, clinical features, diagnosis, treatment, vaccines and prevention COVID-19. This review is in the hope of helping the public and health care professionals effectively recognize and deal with this disease, and providing a reference for future studies.

Cite this article:
B. V. Naresh. A Review of the 2019 Novel Coronavirus (COVID-19) Pandemic. Asian J. Pharm. Res. 2020; 10(3):233-238. doi: 10.5958/2231-5691.2020.00040.4

B. V. Naresh. A Review of the 2019 Novel Coronavirus (COVID-19) Pandemic. Asian J. Pharm. Res. 2020; 10(3):233-238. doi: 10.5958/2231-5691.2020.00040.4   Available on:

1. Indian Ministry of health and family welfare, accessed 15-march-2020
2., accessed 15-march-2020
3. World Health Organization. Coronavirus disease (COVID-2019) situation reports.WHO; 2020. Available from:, accessed on April 15, 2020.
4. Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLoS Med. 2005;2: e174. 
5. Lloyd AL. The dependence of viral parameter estimates on the assumed viral life cycle: limitations of studies of viral load data. Proc Biol Sci. 2001; 268:847–54. 
6. Sanche S, et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020 Jul [date cited]. Available from: URL: eid2607.200282
7. World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014 Available from: 9789241507134_eng.pdf?sequence=1
8. Liu J, et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. Available from: 2020
9. Chan J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020 doi: 10.1016/S0140-6736(20)30154-9
10. Li Q, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; doi:10.1056/NEJMoa2001316.
11. Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. 
12. Burke RM, et al. Active monitoring of persons exposed to patients with confirmed COVID-19 — United States, January–February 2020. MMWR Morb Mortal Wkly Rep. 2020 doi: 10.15585/mmwr.mm6909e1external icon
13. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 16-24 February 2020 [Internet]. Geneva: World Health Organization; 2020 Available from: source/ coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
14. Ong SW, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA.2020 Mar 4 
15. Mode of transmission of virus. Available from: https://
16. Dr. van Doremalen,et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 N Engl J Med 2020; 382:1564-1567 DOI: 10.1056/NEJMc2004973
17. G. Kampf et al. / Journal of Hospital Infection 104 (2020) 246e251
18. Y.L.A. Kwok et al. Face touching: a frequent habit that has implications for hand hygiene. / American Journal of Infection Control 43 (2015) 112-4
19. David A. Schwartz (2020) An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Archives of Pathology and Laboratory Medicine In-Press. Available from: URL:
20. Huaping Zhu, et al. Transl Pediatr 2020;9(1):51-60 | Available from:
21. Symptoms of corona virus, Available from:
22. Chaolin Huang, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Vol 395 February 15, 2020 S0140-6736(20)30183-5 
23. Loss of sense of smell as marker of COVID-19 infection Available from:
24. Some corona virus patients show signs of stroke, seizures. Available from: coronavirus-stroke-seizures-confusion.html
25. k.k., Tsang O.T., et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020
26. Bhadra S., et al. Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV) PLoS One. 2015;10
27. Chan J.F., Choi G.K., Tsang A.K., Tee K.M., Lam H.Y., Yip C.C. Development and evaluation of novel real-time reverse transcription-PCR Assays with locked nucleic acid probes targeting leader sequences of human-pathogenic Coronaviruses. J Clin Microbiol. 2015; 53:2722–2726. 
28. Xie X., et al. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020
29. Ai T., et al. Correlation of chest CT and RT-PCR testing in Coronavirus disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020
30. Shi H., et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20:425–434
31. Xu X., et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020; 47:1275–1280.
32. Wang Y., et al. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J Med Virol. 2020
33. Pool testing of SARS-CoV-02 samples increases worldwide test capacities many times over/ pool-testing-of-sars-cov-02-samples-increases-worldwide-test-capacities-many-times-over/
34. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 published in Clinical Infectious Diseases, ciaa344, available from: cid/ciaa344
35. Chan JF, et al. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 2013; 21:544-55
36. Zhu N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England journal of medicine. 2020
37. Hoffmann M, et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020:2020.01.31.929042.
38. Wrapp D, et al. Cryo-EM structure of the 2019-nCoV spike in the perfusion conformation. Science (New York, NY). 2020.
39. Charalampos Pierrakos, et al. Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options J Clin Med Res  2011; 4(1):7-16
40. Welliver R, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA 2001; 285: 748–54
41. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020; published online March 9. DOI:10.1093/cid/ciaa237
42. 42)Hydroxychloroquine usage recommendations by ICMR Available from: upload_documents/HCQ_Recommendation_22March_final_MM_V2.pdf
43. Existing drugs that may be repurposed to treat coronavirus. Available from: here-are-some-existing-drugs-may-be-repurposed-treat-coronavirus-n1162021
44. Coronavirus treatment. Available from: https://
45. B. Cao, et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19, n engl j med march 18, 2020 DOI: 10.1056/NEJMoa2001282
46. Luo P, et al. Tocilizumab treatment in COVID-19: A single center experience. J Med Virol. 2020 Apr 6. doi: 10.1002/jmv.25801
47. The covid-19 vaccine development landscape, available from:
48. ad5-ncov vaccine moves into phase ii clinical-trials, available from:
49. Mair-Jenkins J, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the 
50. treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015; 211:80-90.
51. convalescent-plasma-therapy-for-covid-19. Available from:
52. Soo YO, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004; 10:676-8 
53. Preventive measures for Covid-19
54. Hemila H. Vitamin C intake and susceptibility to pneumonia. Pediatr Infect Dis J. 1997; 16:836-7.

Recomonded Articles:

Author(s): Dhanashri Aware, Sachin Rohane

DOI: 10.52711/2231-5691.2021.00037         Access: Open Access Read More

Author(s): Vaishnavi. K. Patil, Azam. Z. Shaikh

DOI: 10.5958/2231-5691.2020.00048.9         Access: Open Access Read More

Author(s): Manisha Rokade, Pradnya Khandagale

DOI: 10.5958/2231-5691.2020.00042.8         Access: Open Access Read More

Author(s): Subhashis Debnath, Runa Chakravorty, Donita Devi

DOI: 10.52711/2231-5691.2021.00022         Access: Open Access Read More

Author(s): Ritika Gupta

DOI: 10.5958/2231-5691.2020.00056.8         Access: Open Access Read More

Author(s): Swati G. Talele, Eknath D. Ahire, Khemchand R. Surana, Vijayraj N. Sonawane, Gokul S. Talele

DOI: 10.52711/2231-5691.2022.00008         Access: Closed Access Read More

Author(s): Kandra Naga Vishnu, Praveen Kumar Uppala, Yakaiah Vangoori, Siva Naga Koteswara Rao Gudhanti

DOI: 10.52711/2231-5691.2021.00042         Access: Open Access Read More

Author(s): Ashwini P. Dhruv, Nilesh K. Patel, Ashok B. Patel, Amit Kumar J. Vyas, Ajay I. PatelAshwini P. Dhruv, Nilesh K. Patel, Ashok B. Patel, Amit Kumar J. Vyas, Ajay I. Patel

DOI: 10.52711/2231-5691.2022.00036         Access: Closed Access Read More

Author(s): Manjusha S. Kareppa, Priti B. Savant, Shachi V. Ratnaparkhi, Sohel S. Shaikh, Mohini B. Kadbhane, Someshwar M. Naybal

DOI: 10.52711/2231-5691.2023.00024         Access: Closed Access Read More

Author(s): D. Sunitha, M. Sudhakar

DOI: 10.52711/2231-5691.2023.00021         Access: Closed Access Read More

Author(s): Isha Sharma, Neha Sharma, Michi Moda, Mansi Thakur, Kriti Sharma

DOI: 10.52711/2231-5691.2023.00052         Access: Closed Access Read More

Asian Journal of Pharmaceutical Research (AJPRes.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences. AJPRes. publishes Original Research Articles, Short Communications..... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5691 

Recent Articles